Side effects and photosensitization of human tissues after aminolevulinic acid

Journal of Surgical Research

Volumn 68, Issue 1, 1997, Pages 31-37

  Webber, John ^a   Kessel, David ^a   Fromm, David ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; PROTOPORPHYRIN; RADIOSENSITIZING AGENT;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG TISSUE LEVEL; ETIOLOGY; FEMALE; GASTROINTESTINAL TUMOR; HUMAN; LIVER FUNCTION; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PRIORITY JOURNAL; VOMITING;

EID: 0030907947     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1997.5004     Document Type: Article

References (34)

1. Henderson B. W., Vaughan L., Bellnier D. A., van Leengoed H., Johnson P. G., Oseroff A. R. Photosensitization of murine tumor, vasculature and skin by 5-aminolevulinic acid-induced porphyrin. Photochem. Photobiol. 62:1995;780.
2. Roberts D. J. H., Cairnduff F., Driver I., Dixon B., Brown S. B. Tumour vascular shutdown following photodynamic therapy based on polyhaematoporphyrin or 5-aminolevululinic acid. Int. J. Oncol. 5:1994;763.
3. Star W. E., Marijnissen H. P., van den Berg-Blok A. E., Versteeg J. A., Franken K. A., Reinhold H. S. Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res. 46:1986;2532.
4. Kennedy J. C., Pottier R. H. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J. Photochem. Photobiol. Ser. B Biol. 14:1992;275.
5. Kennedy J. C., Pottier R. H. Using δ-aminolevulinic acid in cancer therapy. ACS Symp. Ser. 559:1994;291.
6. Peng Q., Moan J., Warloe T., Nesland J. M., Rimington C. Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5-aminolevulinic acid in mice bearing mammary carcinoma. Int. J. Cancer. 52:1992;433.
7. Loh C. S., MacRobert A. J., Bedwell J., Regula J., Krasner N., Bown S. G. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. Br. J. Cancer. 68:1993;41.
8. Gossner L., Sroka R., Hahn E. G., Eli C. Photodynamic therapy: Successful destruction of gastrointestinal cancer after oral administration of aminolevulinic acid. Gastroint. Endocrinol. 41:1995;55.
9. Bedwell J., MacRobert A. J., Phillips D., Bown S. G. Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model. Br. J. Cancer. 65:1992;818.
10. Regula J., Ravi B., Bedwell J., MacRobert A. J., Bown S. G. Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer-prolonged animal survival. Br. J. Cancer. 70:1994;248.
11. Wolf P., Fink-Puches R., Cerroni L., Kerl H. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. J. Am. Acad. Dermatol. 31:1994;678.
12. Wolf P., Rieger E., Kerl H. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. J. Am. Acad. Dermatol. 28:1993;17.
13. Grant W. E., Hopper C., MacRobert A. J., Speight P. M., Bown S. G. Photodynamic therapy of oral cancer: Photosensitisation with systemic aminolaevulinic acid. Lancet. 342:1993;147.
14. Fromm D., Kessel D., Webber J. Feasibility of photodynamic therapy using endogenous photosensitization for colon cancer. Arch. Surg. 131:1996;667.
15. Regula J., MacRobert A. J., Gorchein A., Buonaccorsi G. A., Thorpe S. M., Spencer G. M., Hatfield A. R. W., Bown S. G. Photosensitisation and photodynamic therapy of oesophageal, duodenal and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX-a pilot study. Gut. 36:1995;67.
16. J. Webber, D. Kessel, D. Fromm, Photodynamic therapy using endogenous photosensitization for gastrointestinal tumors, Yale J. Biol. Med.
17. Wilson J. H. P., Van Hillegersberg R., Van Den Berg J. W. O. Photodynamic therapy for gastrointestinal tumors. Scand. J. Gastroenterol. 26:1991;20.
18. Leibovici L., Schoenfeld N., Yehoshua H. A. Activity of porphobilinogen deaminase in peripheral blood mononuclear cells of patients with metastatic cancer. Cancer. 62:1988;2297.
19. Lahav M., Epstein O., Schoenfeld N. Increased porphobilinogen deaminase activity in patients with malignant lymphoproliferative disease. J. Am. Med. Assoc. 257:1987;39.
20. Navone N. M., Polo C. F., Frisardi A. L. Heme biosynthesis in human breast cancer-mimetic "in vitro" studies and some heme enzymatic activity levels. Int. J. Biochem. 22:1990;1407.
21. Van Hillegersberg R., Van Den Berg J. W. O., Kort W. J. Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. Gastroenterology. 103:1992;647.
22. El-Sharabasy M. M. H., El-Waseff A. M., Hafez M. M., Salim S. A. Porphyrin metabolism in some malignant diseases. Br. J. Cancer. 65:1992;409.
23. Daily H. A., Smith A. Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase. Biochem. J. 223:1986;441.
24. Schoenfeld N., Epstein O., Lahav M. The heme biosynthetic pathway in lymphocytes of patients with malignant proliferative disorders. Cancer Lett. 43:1991;43.
25. Loh C. S., Bedwell J., MacRobert A. J., Krasner N., Phillips D., Bown S. G. Photodynamic therapy of normal rat stomach: A comparative study between di-sulphonated aluminum phthalocyanine and 5-aminolaevulinic acid. Br. J. Cancer. 66:1992;452.
26. 15. Biochem. J. 64:1956;80.
27. Sibille A., Lambert R., Souquet J.-C., Sabben G., Descos F. Long-term survival after photodynamic therapy for esophageal cancer. Gastroenterology. 108:1995;337.
28. Manyak M. J., Smith P. D., Harrington F. S., Steinberg S. M., Glatstein E., Russo A. Protection against dihematoporphyrin ether photosensitivity. Photochem. Photobiol. 47:1988;823.
29. Peng Q., Warloe T., Moan J., Heyerdahl H., Steen H. B., Nesland J. M., Giercksky K.-E. Distribution of 5-aminolevulinic acid-induced porphyrins in noduloulcerative basal cell carcinoma. Photochem. Photobiol. 62:1995;906.
30. DeLaney T. F., Sindelar W. F., Tochner Z., Smith P. D., Friauf W. S., Thomas G., Dachowski L., Cole J. W., Steinberg S. M., Glatstein E. Phase I study of debulking surgery and photodynamic therapy for disseminated intraperitoneal tumors. Int. J. Radiat. Oncol. Biol. Phys. 25:1993;445.
31. Stein J. A., Curl F. D., Valsamis M., Tschudy D. P. Abnormal iron and water metabolism in acute intermittent prophyria with new morphologic findings. Am. J. Med. 53:1972;784.
32. Barr H., Tralau C. J., MacRobert A. J., Krasner N., Boulos P. B., Clark C. G., Bown S. G. Photodynamic therapy in the normal rat colon with phthalocyanine sensitisation. Br. J. Cancer. 56:1987;111.
33. Potter W. R., Mang T. S., Dougherty T. J. The theory of photodynamic therapy dosimetry: Consequences of photodestruction of sensitizer. Photochem. Photobiol. 46:1987;97.
34. Iinuma S., Bachor R., Flotte T., Hasan T. Biodistribution and phototoxicity of 5-aminolevulinic acid-induced PpIX in an orthotopic rat bladder tumor model. J. Urol. 153:1995;802.